How will the FDA change under the Trump administration and the new FDA Commissioner? This question is in the mind of every food safety professional today.
This webinar by Norma Skolnik will examine the implications of the Trump Administration and President Trump’s pick of Dr. Scott Gottlieb as new FDA Commissioner and Tom Price as Secretary of Health & Human Services on the future of the FDA. Norma will cover Trump’s regulatory agenda, his deregulation task force at federal agencies and his proposed budgetary cuts. She will also discuss in detail, Trump’s new pick for commissioner of the FDA and his intention to ease drug regulations, streamline the Agency and quicken the drug approval process.
Additionally, Norma will provide a detailed background on Tom Price, Trump’s Head of the Dept. of Health & Human Services, as well as on Dr. Scott Gottlieb, the new FDA Commissioner. References and insights will be provided to all relevant laws and regulations and potential FDA changes that could accompany Trump’s agenda and that of the new FDA Commissioner.
Who should attend?
At the Q&A session following the live event, ask a question and get advice unique to your situation, directly from our expert speaker.
Norma Skolnik has over 35 years of regulatory experience working with the pharmaceutical and dietary supplement industries. She served as Director of Regulatory Affairs for the Americas for Cadbury Adams. Prior to that, she was Director of Regulatory Affairs for the Adams Division of Pfizer and Associate Director of Regulatory Affairs for the Warner-Lambert company. She also served as Director of Regulatory Affairs for Lederle Consumer Healthcare and...
More Events By The Speaker